✦ LIBER ✦

Potential of Immobilized Artificial Membranes for Predicting Drug Penetration Across the Blood−Brain Barrier

✍ Scribed by Andreas Reichel; David J. Begley

Book ID: 110305043
Publisher: Springer US
Year: 1998
Tongue: English
Weight: 429 KB
Volume: 15
Category: Article
ISSN: 0724-8741
DOI: 10.1023/a:1011904311149

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nanoparticle technology for delivery of

Nanoparticle technology for delivery of drugs across the blood–brain barrier

✍ Ulrike Schroeder; Petra Sommerfeld; Sven Ulrich; Bernhard A. Sabel 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB

Development of a potential protein vecto

Development of a potential protein vector (NeuroTrans) to deliver drugs across the blood–brain barrier

✍ Reinhard Gabathuler; G. Arthur; M. Kennard; Q. Chen; S. Tsai; J. Yang; W. Schoor 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 145 KB

[Neuromethods] Drug Delivery to the Cent

[Neuromethods] Drug Delivery to the Central Nervous System Volume 45 || Prediction of Blood–Brain Barrier Penetration by Drugs

✍ Jain, Kewal K. 📂 Article 📅 2009 🏛 Humana Press ⚖ 615 KB

Chromatographic indexes on immobilized a

Chromatographic indexes on immobilized artificial membranes for the prediction of transdermal transport of drugs

✍ Francesco Barbato; Brunella Cappello; Agnese Miro; MariaImmacolata La Rotonda; F 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Classification Tree Models for the Predi

Classification Tree Models for the Prediction of Blood—Brain Barrier Passage of Drugs.

✍ Eric Deconinck; Menghui H. Zhang; Danny Coomans; Yvan Vander Heyden 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 8 KB

Humanization of anti-human insulin recep

Humanization of anti-human insulin receptor antibody for drug targeting across the human blood–brain barrier

✍ Ruben J. Boado; Yufeng Zhang; Yun Zhang; William M. Pardridge 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB 👁 2 views

## Abstract A murine monoclonal antibody (MAb) to the human insulin receptor (HIR) has been engineered for use as a brain drug delivery system for transport across the human blood–brain barrier (BBB). The HIRMAb was humanized by complementarity determining region (CDR) grafting on the framework reg